<table className="table"><caption><p>Recommendations for Breast Cancer Screening in Women at Average Risk</p></caption><thead><tr><th colSpan="1" rowSpan="1"><p>Expert Group</p></th><th colSpan="1" rowSpan="1"><p>Recommendation</p></th></tr></thead><tbody><tr className="group_1-1 row-odd"><td colSpan="1" rowSpan="1"><p>American Cancer Society (2015)</p></td><td colSpan="1" rowSpan="1"><p>Age 40-44 y: Provide women with the opportunity to begin annual screening mammography</p><p>Age 45-54 y: Perform annual screening mammography</p><p>Age ≥55 y: Perform biennial screening mammography with the opportunity to continue annual screening</p><p>Do not perform CBE for breast cancer screening</p></td></tr><tr className="group_1-2 row-even"><td colSpan="1" rowSpan="1"><p>American College of Obstetricians and Gynecologists (2017)</p></td><td colSpan="1" rowSpan="1"><p>Age 25-39 y: May offer CBE every 1-3 y</p><p>Age 40-75 y: Perform annual or biennial screening mammography based on a shared decision-making process; offer annual CBE based on a shared decision-making process</p><p>Age &gt;75 y: Engage women in a shared decision-making process about discontinuing screening</p></td></tr><tr className="group_1-3 row-odd"><td colSpan="1" rowSpan="1"><p>American College of Physicians (2019)</p></td><td colSpan="1" rowSpan="1"><p>Age &lt;40 y: Do not perform screening</p><p>Age 40-49 y: Potential harms of screening mammography outweigh benefits in average-risk women. Discuss benefits, harms, and patient preferences; order biennial mammography screening only if an informed woman requests it</p><p>Age 50-74 y: Encourage biennial mammography screening</p><p>Age ≥75 y or life expectancy &lt;10 y: Do not perform screening</p><p>Do not use CBE to screen for breast cancer in average-risk women of all ages</p></td></tr><tr className="group_1-4 row-even"><td colSpan="1" rowSpan="1"><p>American College of Radiology (2017)</p></td><td colSpan="1" rowSpan="1"><p>Age 40 y: Begin annual screening mammography</p></td></tr><tr className="group_1-5 row-odd"><td colSpan="1" rowSpan="1"><p>National Comprehensive Cancer Network (2022)</p></td><td colSpan="1" rowSpan="1"><p>Age 25-39 y: Clinical encounter (medical and family history, risk assessment/risk reduction counseling, and preferably CBE) every 1-3 y</p><p>Age 40 y: Begin annual screening mammography, preferably with tomosynthesis, and annual clinical encounter</p><p>Breast awareness, defined as having familiarity with one's breasts and reporting changes to the health care provider, is recommended for all age-groups</p></td></tr><tr className="group_1-6 row-even"><td colSpan="1" rowSpan="1"><p>U.S. Preventive Services Task Force (2024)</p></td><td colSpan="1" rowSpan="1"><p>Age 40-74 y: Perform biennial screening mammography (grade B)</p><p>Age ≥75 y: Insufficient evidence to assess the balance of benefits and harms of screening mammography (I statement)</p></td></tr></tbody></table>